A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Norman Wolmark, MD
NSABP Foundation Inc
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
533 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Bon Secours Hospital
Cork, CK, Ireland
- Letterkenny General Hospital
Letterkenny, DL, Ireland
- Mater Private Hospital
Dublin, DN, Ireland
- Beaumont Hospital
Dublin, Ireland
- Mater Misericordiae
Dublin, Ireland
- St James' Hospital
Dublin, Ireland
- St. James' Hospital
Dublin, Ireland
- St. Vincent'S University Hospital
Dublin, Ireland
- University College Hospital
Galway, Ireland
- Sligo General Hospital
Sligo, Ireland
- Waterford Regional Hospital
Waterford, Ireland
- Birmingham Hematology and Oncology
Bessemer, Alabama, United States
- Birmingham Hematology and Oncology
Birmingham, Alabama, United States
- Birmingham Hematology and Oncology - Brookwood
Birmingham, Alabama, United States
- Birmingham Hematology and Oncology - Montclair
Birmingham, Alabama, United States
- Birmingham Hematology and Oncology - Pilot
Birmingham, Alabama, United States
- Birmingham Hematology and Oncology - Princeton
Birmingham, Alabama, United States
- Clearview Cancer Institute- Huntsville
Huntsville, Alabama, United States
- Northern Arizona Hematology & Onclogy Associates
Flagstaff, Arizona, United States
- Arizona Oncolocy (casa-Green Valley)
Green Valley, Arizona, United States
- Arizona Oncology (casa- Oro Valley)
Oro Valley, Arizona, United States
- Hematology Oncology Associates
Phoenix, Arizona, United States
- Northern Arizona Hematology & Oncology Associates
Prescott Valley, Arizona, United States
- Arizona Oncology (casa-Safford)
Safford, Arizona, United States
- Hematology Oncology Associates
Scottsdale, Arizona, United States
- Northern Arizona Hematology & Oncology Associates
Sedona, Arizona, United States
- Arizona Oncology (casa-Craycroft)
Tucson, Arizona, United States
- Arizona Oncology (casa-Office Only)
Tucson, Arizona, United States
- Arizona Oncology - Casa St. Mary'S
Tucson, Arizona, United States
- Arizona Oncology Associates - Carondelet
Tucson, Arizona, United States
- Arizona Oncology Associates - Rudasill
Tucson, Arizona, United States
- Central Hematology/oncology Medical Group, Inc.
Alhambra, California, United States
- Kaiser Permanente Deer Valley Med Center
Antioch, California, United States
- Comp Blook and Cancer Center
Bakersfield, California, United States
- Southwest Cancer Care (e. Grand)
Escondido, California, United States
- Kaiser Permanente Fremont
Fremont, California, United States
- St. Jude Heritage Healthcare
Fullerton, California, United States
- Kaiser Permanente Medical Center - Hayward
Hayward, California, United States
- Pacific Shores Medical Group
Huntington Beach, California, United States
- Southern California Permanente Medical Group
Irvine, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2009
- Primary completion
- 28 Feb 2018
- Completion
- 28 Feb 2018
- Last update posted
- 20 Apr 2022
- Registered enrollment
- 1,613
- Registry id
- NCT00887536
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.